Back
ProShares Ultra S&P500 Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
55
SSO
ProShares Ultra S&P500
Last Price:
$56.58
Seasonality Move:
0.19%
Sell
36
MNPR
Monopar Therapeutics, Inc.
Last Price:
$71.77
Seasonality Move:
36.18%
Buy
55
ProShares Ultra S&P500 (SSO)
is a Buy
Is ProShares Ultra S&P500 a Buy, Sell or Hold?
-
The current ProShares Ultra S&P500 [SSO] share price is $57.34. The Score for SSO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
SSO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SSO Stock Price Chart
What is ProShares Ultra S&P500's stock price today?
-
The ProShares Ultra S&P500 share price today is $57.34The current trend is moderately bearish and SSO is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $71.47Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
SSO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 49.15 | Sell |
| Chaikin Money Flow: | 933335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.59 - 58.75) | Buy |
| Bollinger Bands (100): | (52.63 - 57.73) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.27 | Sell |
| Relative Strength Index (14 RSI): | 37.77 | Sell |
| Chaikin Money Flow: | -61015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
SSO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.23 | Sell |
| 20-day SMA: | 57.19 | Buy |
| 50-day SMA: | 57.05 | Buy |
| 200-day SMA: | 49.43 | Buy |
| 8-day EMA: | 57.95 | Sell |
| 20-day EMA: | 57.65 | Sell |
| 50-day EMA: | 56.8 | Buy |
| 200-day EMA: | 51.66 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.09 | Sell |
| 20-day SMA: | 80.86 | Sell |
| 50-day SMA: | 83.38 | Sell |
| 200-day SMA: | 51.78 | Buy |
| 8-day EMA: | 75.84 | Sell |
| 20-day EMA: | 78.85 | Sell |
| 50-day EMA: | 77.98 | Sell |
| 200-day EMA: | 56.35 | Buy |
ProShares Ultra S&P500 Earnings Growth & SSO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
ProShares Ultra S&P500 Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||